semaglutide hepatotoxicity case report Semaglutide‐Induced Hepatic Injury: A Rare of Drug Induced Liver Injury A Placebo-Controlled Trial of Subcutaneous

The warning signs include: Severe, worsening abdominal pain that does not resolve Vomiting undigested food many hours after eating (4+ hours) Complete inability to keep food down for more than 24 hours Feeling full after just a few bites consistently across multiple days Visible, persistent abdominal distension that does not fluctuate Unintentional weight loss beyond what is expected from the medication Inability to pass gas or have bowel movements for 3+ days If you experience these symptoms, stop taking semaglutide and contact your healthcare provider immediately

Semaglutide with B12 is a compounded medication

Distilled off the solvent from the reaction mixture under reduced pressure and co-distilled with toluene followed by with MTBE

GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomised controlled trials